News
On April 15, 2024, Sung Lee, Executive Vice President And Chief Financial Officer Of Vir Biotechnology Informed The Company That He Will Be Stepping Down From His Role, Effective May 3, 2024, To Pursue Another Career Opportunity; Co Has Initiated A Search For His Successor
18 Apr 24
News, Management
Assessing Vir Biotechnology: Insights From 5 Financial Analysts
15 Mar 24
Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Vir Biotechnology, Maintains $110 Price Target
15 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
23 Feb 24
Earnings, News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Carvana Posts Q4 Results, Joins LegalZoom.com, Comfort Systems And Other Big Stocks Moving Higher On Friday
23 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Vir Biotechnology Q4 2023 GAAP EPS $(0.86) Beats $(1.00) Estimate, Sales $16.79M Beat $12.15M Estimate
22 Feb 24
Earnings, Earnings Beats, News
Earnings Scheduled For February 22, 2024
22 Feb 24
Earnings
Earnings Outlook For Vir Biotechnology
21 Feb 24
Earnings
HC Wainwright & Co. Maintains Buy on Vir Biotechnology, Raises Price Target to $110
14 Feb 24
News, Price Target, Analyst Ratings
JP Morgan Downgrades Vir Biotechnology: Here's What You Need To Know
29 Jan 24
Analyst Ratings
JP Morgan Downgrades Vir Biotechnology to Neutral, Lowers Price Target to $9
29 Jan 24
News, Downgrades, Price Target, Analyst Ratings
Press releases
Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024
11 Apr 24
Press Releases
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results
22 Mar 24
Earnings, Press Releases
Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule
5 Mar 24
Press Releases
Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
23 Feb 24
Press Releases
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
22 Feb 24
Press Releases
Vir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical Officer
20 Feb 24
Press Releases
Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024
1 Feb 24
Press Releases